Tag

Car T Cell Therapy

All articles tagged with #car t cell therapy

entertainment11 hours ago•2 min saved

Jurassic Park star Sam Neill dies at 78 after cancer battle and exhausting treatment

Sam Neill, the Jurassic Park actor, has died at 78 after a battle with stage 3 angioimmunoblastic T-cell lymphoma. His ex, Laura Tingle, said the cancer and its treatments left him immunocompromised and exhausted, though he was declared cancer-free in April after a CAR T-cell therapy trial. The family announced his death as sudden and unexpected, noting he remained cancer-free and thanking his hospital staff; tributes from co-stars followed as Neill’s dedication to acting and resilience were highlighted.

via USA Today|

#angioimmunoblastic-t-cell-lymphoma #cancer #car-t-cell-therapy

health22 days ago•42 min saved

CAR-T Lupus Breakthrough Drives Remission and Cure-Hope in Trial

A UK trial at University College London Hospital using CAR T-cell therapy to treat lupus nephritis showed remission in five of nine patients within three months, with remissions lasting through an 11-month follow-up, including a patient who fulfilled a skiing dream—an advance that researchers say could herald a lupus cure if confirmed in larger studies.

via Good News Network|

#car-t-cell-therapy #health #immunotherapy

science5 months ago•7 min saved

Immune Therapy Reboots Aging Gut, Delivering Year-Long Regeneration in Mice

Cold Spring Harbor Laboratory researchers used anti-uPAR CAR T cells to selectively clear senescent cells in aging intestinal tissue, boosting epithelial regeneration, reducing inflammation, and improving nutrient absorption in both young and old mice. After radiation-induced gut damage, treated mice recovered more fully, with benefits persisting for at least a year. Early data also show regeneration signals in human intestinal and colorectal cells, suggesting potential clinical trials to counter age-related gut decline.

via SciTechDaily|

#aging #car-t-cell-therapy #gut-health

health6 months ago•3 min saved

First-In-Body Engineering of Cancer-Fighting Cells

Scientists have successfully engineered cancer-fighting T-cells inside patients' bodies for the first time, potentially making CAR T-cell therapy faster, cheaper, and more accessible for treating multiple myeloma, with promising early results and manageable side effects.

via Good News Network|

#cancer #car-t-cell-therapy #health

health8 months ago•3 min saved

UK's First MS Patient Trials Groundbreaking 'Gamechanger' Treatment

A Hertfordshire mother and biology teacher, Emily Henders, has become the first UK patient to receive a pioneering CAR T cell therapy in a clinical trial aimed at treating multiple sclerosis, a disease that causes immune system attacks on nerves. The experimental treatment, which depletes B cells to reset the immune system, offers hope for slowing or halting disease progression and could be a gamechanger if successful.

via BBC|

#autoimmune-disease #car-t-cell-therapy #clinical-trial

health1 year ago•6 min saved

Breakthrough Immunotherapy Extends Lives in Multiple Myeloma Patients

A new FDA-approved treatment called Carvykti, a CAR T-cell therapy developed by Legend Biotech in New Jersey, offers a potential 'functional cure' for multiple myeloma, significantly extending remission periods and improving quality of life for patients like Carmen Phaneuf, who has managed to stay in remission for nearly three years after treatment.

via NJ.com|

#cancer #car-t-cell-therapy #carvykti

health1 year ago•5 min saved

Boosting CAR-T Therapy with the Ketogenic Diet

A study from the University of Pennsylvania suggests that a ketogenic diet enhances the effectiveness of CAR T cell therapy in treating lymphoma by utilizing beta-hydroxybutyrate (BHB) as a preferred energy source over glucose. This approach led to improved tumor control and survival in mice, with translational studies indicating similar benefits in human samples. A Phase I clinical trial is underway to test BHB supplementation in lymphoma patients, potentially offering a low-toxicity, cost-effective strategy to boost cancer immunotherapy outcomes.

via Neuroscience News|

#beta-hydroxybutyrate #cancer-treatment #car-t-cell-therapy

health1 year ago•3 min saved

Breakthrough Treatment Rapidly Eliminates Brain Tumors

A new CAR T-cell therapy shows promise in treating glioblastoma, a deadly brain cancer, by using the patient's immune system to target cancer cells. In a small trial, one patient experienced significant tumor shrinkage without recurrence, while two others saw initial improvements but later relapsed. Despite mixed results, the therapy offers hope for a cancer with limited treatment options, prompting further research.

via Greek Reporter|

#cancer-treatment #car-t-cell-therapy #clinical-trials

health1 year ago•2 min saved

Revolutionary Cell Therapy Offers Hope for Autoimmune Diseases

A new treatment for lupus, using CAR T-cell therapy, is being hailed as groundbreaking, potentially eliminating the need for lifelong medication. This therapy, which genetically modifies a patient's cells to fight the autoimmune disease, has shown promising results in Germany, with patients achieving remission. In the UK, three patients have received the treatment, including a 32-year-old woman who reported improved energy and reduced symptoms. The therapy, previously used for cancer, could revolutionize lupus treatment and possibly lead to a cure, though it involves risks such as increased infection susceptibility.

via The Guardian|

#autoimmune-disease #car-t-cell-therapy #clinical-trial

medical-breakthrough2 years ago•3 min saved

"Revolutionary Therapy Rapidly Shrinks Deadly Brain Tumors in Early Trials"

A new immunotherapeutic approach using CAR T-cell therapy has shown promising results in treating glioblastoma, a deadly form of brain cancer. In a small clinical trial, one patient experienced a significant reduction in tumor size within days of receiving the treatment, while others saw mixed outcomes. The therapy targets a mutated protein prevalent in glioblastomas, and researchers are optimistic about its potential as a treatment, although long-term effectiveness is still unknown. Further study and clinical trials are needed to determine the therapy's efficacy in treating this incurable disease.

via ScienceAlert|

#cancer #car-t-cell-therapy #glioblastoma

health2 years ago•4 min saved

"Promising Results: Innovative Immunotherapy Shrinks Deadly Brain Tumors in Early Trials"

Early clinical trials have shown promise for a new immune cell-based treatment, CAR T-cell therapy, in shrinking tumors in patients with recurrent glioblastoma, a highly aggressive form of brain cancer. The therapy involves genetically modifying patients' immune cells to better recognize and attack tumors. While the treatment was found to be safe and reduced tumor size in all nine patients, the effects were not necessarily long-lasting. More data is needed to evaluate the longer-term effects and broader relevance of these new treatments, but researchers are optimistic about the potential of CAR T-cell therapy to make a difference in solid tumors, especially in the brain.

via Livescience.com|

#cancer #car-t-cell-therapy #clinical-trials

medical-breakthrough2 years ago•2 min saved

"Promising Results: CAR-T Cell Therapy Shrinks Brain Tumors in Early Trials"

A clinical trial for CAR-T cell therapy in patients with glioblastoma, a deadly form of brain cancer, has shown promising results, with some patients experiencing significant tumor regression just days after treatment. The therapy, which uses a patient's own immune cells to target the tumor, resulted in near-complete tumor regression in one patient after five days. The researchers emphasize the need for further research to refine this treatment, but are optimistic about its potential to change the outlook for this challenging disease.

via Good News Network|

#brain-cancer #car-t-cell-therapy #clinical-trial

health-medicine2 years ago•2 min saved

"Promising Results: Innovative Treatments Shrink Aggressive Brain Tumors in Clinical Trials"

A new form of CAR-T cell therapy, called CAR-TEAM, has shown promising results in shrinking aggressive glioblastoma brain tumors in a small clinical trial at Mass General Cancer Center. Three patients experienced significant tumor shrinkage after a single infusion, with one patient's tumor remaining nearly undetectable during the follow-up period. While two patients saw tumor regrowth within six months, researchers are hopeful about the early signs of efficacy and plan to enhance the treatment's durability by combining it with chemotherapy.

via The Boston Globe|

#brain-cancer #car-t-cell-therapy #glioblastoma

health-medicine2 years ago•5 min saved

"Living Cell Therapy Shows Dramatic Progress Against Glioblastoma Tumors"

A phase 1 clinical trial at the Mass General Cancer Center has shown promising early results in treating glioblastoma, a lethal brain cancer, with a novel CAR-T cell therapy. The treatment, which involves specially engineered T-cells injected directly into the fluid around the brain, has demonstrated dramatic and rapid tumor reduction in early trials. While more research is needed, the initial findings provide hope for improved treatment options for this aggressive form of cancer.

via WCVB Boston|

#cancer-treatment #car-t-cell-therapy #clinical-trial

medical-research2 years ago•20 min saved

"Supercharged T Cell Mutations Revolutionize Cancer Immunotherapy"

Researchers have discovered naturally occurring T cell mutations that can enhance engineered T cell therapies for cancer treatment. The study, published in Nature, highlights the potential of leveraging these mutations to improve the efficacy of CAR T cell therapy. The findings provide insights into the genomic landscape of T cell lymphomas and the mechanisms underlying T cell signaling and differentiation. This research contributes to the ongoing efforts to advance cancer immunotherapy and develop more effective treatments for patients with refractory cancer.

via Nature.com|

#cancer-immunotherapy #car-t-cell-therapy #engineered-t-cell-therapies